Thalomid thalidomide: Phase I/II

In interim results from a U.S. 15-patient Phase I portion of a Phase I/II trial, CELG said Thalomid plus IL-2 led to partial responses in 5 of 10 evaluable patients; 2 patients had stable disease. Dat...